CMOC Group Limited - 3993.HK

3993.HK Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
3993.HK	-1.5	0.5	8.1	-18.8	-17.2	45.7	36.0	63.5	261.0	59.0
S&P 500	1.0	1.5	1.1	2.3	8.9	23.6	33.8	80.6	196.5	33856.2

Compare 3993.HK with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	3993.HK
name	CMOC Group Limited
price	5.74
changes percentage	-1.5437
change	-0.09
day low	5.71
day high	5.9
year high	8.57
year low	3.84
market cap	154210534006
price avg 50	5.7044
price avg 200	6.6467
exchange	HKSE
volume	23338939
avg volume	25094712
open	5.88
previous close	5.83
eps	0.7
pe	8.2
earnings announcement	2025-04-01T12:00:00.000+0000
shares outstanding	26865946691
timestamp	2025-01-20 08:08:32

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 39.0%

Overall Quarterly Financial Health: 51.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	186268971919	172990857221	7.68
gross profit	17831942018	16064609090	11.00
gross profit ratio	0.1	0.09	3.09
research and development expenses	327085170	388609726	-15.83
operating expenses	4543963862	3426353426	32.62
interest income	465711045	1189038307	-60.83
interest expense	4138052209	2682853052	54.24
ebitda	14708951829	17097962533	-13.97
ebitdaratio	0.08	0.11	-25.02
operating income	13287978156	13732802118	-3.24
operating income ratio	0.07	0.08	-10.14
net income	8249711872	6066946564	35.98
net income ratio	0.04	0.04	26.28
eps	0.38	0.28	35.71

Overall Score of Annual Income Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 186,269 million in 2023 from 172,991 million in 2022 representing a change of 7.68%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 17,832 million in 2023 from 16,065 million in 2022 representing a change of 11.0%. This indicates a sales profitability growth, which is a positive sign for the company.

  Net Income: Net income increased to 8,250 million in 2023 from 6,067 million in 2022 representing a change of 35.98%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.38 in 2023 from 0.38 in 2022 representing a change of 35.71%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 327 million in 2023 from 389 million in 2022 representing a change of -15.83%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 4,544 million in 2023 from 3,426 million in 2022 representing a change of 32.62%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 14,709 million in 2023 from 17,098 million in 2022 representing a change of -13.97%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 13,288 million in 2023 from 13,733 million in 2022 representing a change of -3.24%. The decrease in operating income indicates worse operational performance and decreased profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
revenue	56697052172	46121379515	22.93
gross profit	12896489073	5899735231	118.59
gross profit ratio	0.23	0.13	77.82
research and development expenses	85409395	51796305	64.89
operating expenses	5276430887	1738479838	203.51
interest income	405828915	329921260	23.01
interest expense	901594874	954634793	-5.56
ebitda	8513708676	4602423006	84.98
ebitdaratio	0.15	0.1	55.32
operating income	7620058186	3526330231	116.09
operating income ratio	0.13	0.08	75.78
net income	3345568728	2071690611	61.49
net income ratio	0.06	0.04	31.37
eps	0.16	0.1	60.00

Overall Score of Quarterly Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 56,697 million in 2024Q2 from 46,121 million in 2024Q1 representing a change of 22.93%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 12,896 million in 2024Q2 from 5,900 million in 2024Q1 representing a change of 118.59%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 85 million in 2024Q2 from 52 million in 2024Q1 representing a change of 64.89%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 8,514 million in 2024Q2 from 4,602 million in 2024Q1 representing a change of 84.98%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 7,620 million in 2024Q2 from 3,526 million in 2024Q1 representing a change of 116.09%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 3,346 million in 2024Q2 from 2,072 million in 2024Q1 representing a change of 61.49%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.16 in 2024Q2 from 0.16 in 2024Q1 representing a change of 60.0%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 5,276 million in 2024Q2 from 1,738 million in 2024Q1 representing a change of 203.51%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	172974530702	165019219538	4.82
total liabilities	101012356495	102981802839	-1.91
total equity	71962174207	62037416698	16.00
cash and cash equivalents	30716077208	32647565268	-5.92
short term investments	8284638370	4236792942	95.54
long term investments	-2848787543	1266421262	-324.95
total current assets	83647583348	85681792329	-2.37
total non current assets	89326947353	79337427209	12.59
total current liabilities	48980272404	50061116758	-2.16
total non current liabilities	52032084090	52920686080	-1.68
common stock	4319848116	4319848116	0.00
retained earnings	23977727693	18019893163	33.06
total debt	50864931651	48347067797	5.21

Overall Score of Annual Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 172,975 million in 2023 from 165,019 million in 2022 representing a change of 4.82%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 101,012 million in 2023 from 102,982 million in 2022 representing a change of -1.91%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 71,962 million in 2023 from 62,037 million in 2022 representing a change of 16.0%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 8,285 million in 2023 from 4,237 million in 2022 representing a change of 95.54%. This indicates an increase in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities decreased to 48,980 million in 2023 from 50,061 million in 2022 representing a change of -2.16%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 23,978 million in 2023 from 18,020 million in 2022 representing a change of 33.06%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 30,716 million in 2023 from 32,648 million in 2022 representing a change of -5.92%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 83,648 million in 2023 from 85,682 million in 2022 representing a change of -2.37%. This indicates a worsen liquidity position.

  Total Debt: Total Debt increased to 50,865 million in 2023 from 48,347 million in 2022 representing a change of 5.21%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
total assets	185879882077	177594836148	4.67
total liabilities	109964951566	102914175370	6.85
total equity	75914930510	74680660776	1.65
cash and cash equivalents	34912919090	31142073302	12.11
short term investments	14389303033	11964139498	20.27
long term investments	-8702245012	-6539979133	-33.06
total current assets	95678153975	87970212943	8.76
total non current assets	90201728101	89624623204	0.64
total current liabilities	63112476130	53555635857	17.84
total non current liabilities	46852475435	49358539512	-5.08
common stock	4319848116	4319848116	0.00
retained earnings	26094914688	26049418305	0.17
total debt	53576889227	43986518628	21.80

Overall Score of Quarterly Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 185,880 million in 2024Q2 from 177,595 million in 2024Q1 representing a change of 4.67%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 75,915 million in 2024Q2 from 74,681 million in 2024Q1 representing a change of 1.65%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 34,913 million in 2024Q2 from 31,142 million in 2024Q1 representing a change of 12.11%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 14,389 million in 2024Q2 from 11,964 million in 2024Q1 representing a change of 20.27%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 95,678 million in 2024Q2 from 87,970 million in 2024Q1 representing a change of 8.76%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 26,095 million in 2024Q2 from 26,049 million in 2024Q1 representing a change of 0.17%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 109,965 million in 2024Q2 from 102,914 million in 2024Q1 representing a change of 6.85%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 63,112 million in 2024Q2 from 53,556 million in 2024Q1 representing a change of 17.84%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 53,577 million in 2024Q2 from 43,987 million in 2024Q1 representing a change of 21.8%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-2926784674	8652857807	-133.82
operating cash flow	15542003495	15453761072	0.57
free cash flow	2617605364	4936001801	-46.97
capital expenditure	-12924398131	-10517759270.88	-22.88
depreciation and amortization	2813382624	4486280835	-37.29
deferred income tax	0	-63616598.83	100.00
stock based compensation	41951356	0	NaN
accounts payables	0	-2863481918.27	100.00
inventory	411755387	-5612705132.9	107.34
acquisitions net	1010846451	73757200	1270.51
investments in property plant and equipment	-12924398131	-10517759270.88	-22.88
net cash used for investing activites	-10658686269	-7371654238.67	-44.59
debt repayment	-2164178576.38	-1876313501.49	-15.34
common stock issued	0	499999996	-100.00
common stock repurchased	0	-499999996	100.00
dividends paid	-6762255256.09	-4791671968.37	-41.13
net cash used provided by financing activities	-8606467553	-2096545911.51	-310.51
cash at end of period	26118763976	29045548650	-10.08
accounts receivables	-2637805522	2863481919	-192.12
cash at beginning of period	29045548650	20392690843	42.43

Overall Score of Annual Cashflow Statement

None

Detailed Analysis

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
operating cash flow	0	5477822704	-100.00
free cash flow	-2305022373.98	3817663643	-160.38
capital expenditure	-2305022373.98	-1660159060.32	-38.84
depreciation and amortization	0	0	NaN
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	-4635988.54	155954700	-102.97
investments in property plant and equipment	-2305022373.98	-1660159060.32	-38.84
net cash used for investing activites	-4052613447.21	-2953578573.4	-37.21
debt repayment	4237870143	-334898253.19	1365.42
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-1572016208.1	-855524200.55	-83.75
net cash used provided by financing activities	3132653276	-2150097140.16	245.70
net change in cash	4394448229	404486039	986.43
cash at end of period	30917698244	26523250015	16.57
cash at beginning of period	26523250015	26118763976	1.55

Overall Score of Quarterly Cashflow Statement

None

Detailed Analysis

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	8.72	8.1	7.60
net income per share	0.39	0.28	35.89
operating cash flow per share	0.73	0.72	0.50
free cash flow per share	0.12	0.23	-47.01
cash per share	1.82	1.73	5.67
book value per share	3.37	2.9	15.92
tangible book value per share	2.27	1.97	15.11
shareholders equity per share	2.79	2.42	15.09
interest debt per share	2.59	2.39	8.26
market cap	111137701277.2	97179358981.25	14.36
enterprise value	131286555720.2	112878861510.25	16.31
pe ratio	13.47	16.02	-15.90
price to sales ratio	0.6	0.56	6.21
pocfratio	7.15	6.29	13.71
pfcf ratio	42.46	19.69	115.65
pb ratio	1.87	1.88	-0.70
ptb ratio	1.87	1.88	-0.70
ev to sales	0.7	0.65	8.02
enterprise value over ebitda	6.52	6.82	-4.39
ev to operating cash flow	8.45	7.3	15.65
ev to free cash flow	50.16	22.87	119.32
earnings yield	0.07	0.06	18.90
free cash flow yield	0.02	0.05	-53.63
debt to equity	0.85	0.94	-8.65
debt to assets	0.29	0.29	0.37
net debt to ebitda	1.0	0.95	5.50
current ratio	1.71	1.71	-0.22
interest coverage	3.01	5.12	-41.23
income quality	1.82	2.15	-15.21
dividend yield	0.06	0.02	259.70
payout ratio	0.76	0.25	202.52
sales general and administrative to revenue	0.0	0.0	16.65
research and ddevelopement to revenue	0.0	0.0	-21.83
intangibles to total assets	0.14	0.12	12.30
capex to operating cash flow	0.83	0.68	22.18
capex to revenue	0.07	0.06	14.12
capex to depreciation	4.49	2.34	91.49
stock based compensation to revenue	0.0	0	NaN
graham number	4.92	3.93	25.06
roic	0.06	0.07	-21.38
return on tangible assets	0.06	0.04	31.95
graham net net	-2.12	-2.04	-3.59
working capital	34667310944	35620675571	-2.68
tangible asset value	48571648249	42166934499	15.19
net current asset value	-17364773147	-17300010510	-0.37
invested capital	104628309016	97470298396	7.34
average receivables	4907058998	6507969818	-24.60
average payables	2287000512	932827115.5	145.17
average inventory	31842609223	29607343439	7.55
days sales outstanding	2.73	17.77	-84.65
days payables outstanding	7.71	2.37	225.50
days of inventory on hand	68.11	75.02	-9.21
receivables turnover	133.78	20.54	551.31
payables turnover	47.36	154.17	-69.28
inventory turnover	5.36	4.87	10.15
roe	0.14	0.12	18.07
capex per share	0.6	0.49	22.80

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 13.47 on 2023-12-31 from 16.02 on 2022-12-31, representing a change of -15.90%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.71 on 2023-12-31 from 1.71 on 2022-12-31, representing a change of -0.22%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.85 on 2023-12-31 from 0.94 on 2022-12-31, representing a change of -8.65%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
3993.HK
calendar year	2024	2024	NaN
revenue per share	2.38	2.6	-8.61
net income per share	0.13	0.16	-14.64
operating cash flow per share	0.34	0.25	35.87
free cash flow per share	0.29	0.14	110.15
cash per share	2.13	2.46	-13.53
book value per share	3.6	3.51	2.78
tangible book value per share	2.58	3.46	-25.43
shareholders equity per share	2.95	2.85	3.48
interest debt per share	2.54	2.77	-8.44
market cap	185941923290.7	185087017896.26	0.46
enterprise value	206928696485.7	208488842075.26	-0.75
pe ratio	16.28	13.83	17.70
price to sales ratio	3.66	3.33	9.93
pocfratio	25.82	34.92	-26.06
pfcf ratio	29.55	61.8	-52.20
pb ratio	2.95	3.03	-2.92
ptb ratio	2.95	3.03	-2.92
ev to sales	4.07	3.75	8.60
enterprise value over ebitda	32.44	21.21	52.98
ev to operating cash flow	28.74	39.34	-26.95
ev to free cash flow	32.88	69.62	-52.77
earnings yield	0.02	0.02	-15.04
free cash flow yield	0.03	0.02	109.18
debt to equity	0.84	0.96	-11.86
debt to assets	0.29	0.31	-6.70
net debt to ebitda	3.29	2.38	38.23
current ratio	1.46	1.52	-3.51
interest coverage	6.45	12.66	-49.07
income quality	2.52	1.58	59.18
dividend yield	0	0.01	-100.00
payout ratio	0	0.47	-100.00
sales general and administrative to revenue	0	-0.0	100.00
research and ddevelopement to revenue	0.0	0.0	11.97
intangibles to total assets	0.12	0.01	1987.96
capex to operating cash flow	0.13	0.43	-71.03
capex to revenue	0.02	0.04	-56.93
capex to depreciation	0	1.68	-100.00
stock based compensation to revenue	0	0.0	-100.00
graham number	2.98	3.17	-6.02
roic	0.02	0.04	-36.64
return on tangible assets	0.02	0.02	-1.28
graham net net	-1.78	-1.72	-3.70
working capital	29416993588	32565677845	-9.67
tangible asset value	55090048798	73875159725	-25.43
net current asset value	-11715971328	-15251760035	23.18
invested capital	97822541854	81092402849	20.63
average receivables	7021083545	4466471838.5	57.20
average payables	5654474776	4721969521.5	19.75
average inventory	31982687092	31047270741.5	3.01
days sales outstanding	11.74	11.99	-2.05
days payables outstanding	11.06	12.25	-9.70
days of inventory on hand	66.33	65.56	1.18
receivables turnover	7.67	7.51	2.09
payables turnover	8.14	7.35	10.74
inventory turnover	1.36	1.37	-1.16
roe	0.05	0.05	-17.52
capex per share	0.04	0.11	-60.64

• Negative

  ROE: Return on Equity (ROE) decreased to 0.05 on 2024-09-30 Q3 from 0.05 on 2024-06-30 Q2, representing a change of -17.52%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 16.28 on 2024-09-30 Q3 from 13.83 on 2024-06-30 Q2, representing a change of 17.70%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.84 on 2024-09-30 Q3 from 0.96 on 2024-06-30 Q2, representing a change of -11.86%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Neutral

  Current Ratio: Current Ratio decreased to 1.46 on 2024-09-30 Q3 from 1.52 on 2024-06-30 Q2, representing a change of -3.51%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 2.79 which is lower than current price 5.74, indicates the company may be overvalued.